Health Technology Assessment (HTA)



The HTA Programme funds research about the clinical and cost effectiveness and broader impact of healthcare treatments and tests for those who plan, provide or receive care in the NHS. HTA research is undertaken where some evidence already exists to show that a technology can be effective and this needs to be compared to the current standard NHS intervention to see which works best.

The term ‘health technology’ can cover any intervention used in the treatment, prevention or diagnosis of disease. This could mean research evaluating for example, devices, procedures, drugs, settings of care or screening, provided the study outcomes lead to findings that have the potential to be of direct benefit to NHS patients.

The HTA Programme has two main workstreams: researcher-led and commissioned.

The researcher-led workstream, Clinical Evaluation and Trials (CET), offers researchers the opportunity to submit proposals on topics or research questions within the programme’s remit. There are three cut-off dates a year when applications will be considered.

The commissioned workstream invites applications in response to calls for research on specific questions which have been identified and prioritised for their importance to the NHS and patients. Proposals may include primary research, evidence synthesis, or feasibility and pilot studies.

Calls/Competitions Researcher-led and commissioned calls
Application process Primary research - two stage*
Evidence synthesis - one stage*
* Flexible depending on the type of call

For a list of NIHR funding deadlines
take a look at our funding deadlines page.


Contact us   Connect with us Connect with us on Google+ Connect with us on YouTube
© 2017 RDS South West | Design by Russell Holloway